Top-Rated StocksTop-RatedNASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis → The only AI company you should be looking at (From Behind the Markets) (Ad) Free IRTC Stock Alerts $102.29 +0.20 (+0.20%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$101.29▼$105.1450-Day Range$102.09▼$123.6152-Week Range$70.24▼$140.23Volume391,058 shsAverage Volume425,279 shsMarket Capitalization$3.17 billionP/E RatioN/ADividend YieldN/APrice Target$135.11 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get iRhythm Technologies alerts: Email Address iRhythm Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside32.1% Upside$135.11 Price TargetShort InterestBearish5.81% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.16Based on 14 Articles This WeekInsider TradingSelling Shares$5.02 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($3.14) to ($1.98) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.47 out of 5 starsMedical Sector757th out of 947 stocksSurgical & Medical Instruments Industry85th out of 99 stocks 3.5 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $135.11, iRhythm Technologies has a forecasted upside of 32.1% from its current price of $102.29.Amount of Analyst CoverageiRhythm Technologies has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.81% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 44.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 2.9 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.Search Interest5 people have searched for IRTC on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.MarketBeat Follows9 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,020,633.00 in company stock.Percentage Held by InsidersOnly 0.43% of the stock of iRhythm Technologies is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($3.14) to ($1.98) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -25.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -25.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 14.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency About iRhythm Technologies Stock (NASDAQ:IRTC)iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More IRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRTC Stock News HeadlinesMarch 18, 2024 | stockhouse.comUPCOMING IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit!March 16, 2024 | nasdaq.comCommit To Buy iRhythm Technologies At $70, Earn 6.9% Annualized Using OptionsMarch 18, 2024 | Porter & Company (Ad)My next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.March 16, 2024 | prnewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTCMarch 16, 2024 | finance.yahoo.comIRTC Jan 2025 130.000 callMarch 16, 2024 | finance.yahoo.comIRTC Jan 2025 80.000 putMarch 16, 2024 | finance.yahoo.comIRTC Apr 2024 160.000 callMarch 15, 2024 | prnewswire.comIRHYTHM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTCMarch 18, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.March 15, 2024 | stockhouse.comIRTC SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action LawsuitMarch 15, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of iRhythm Technologies, Inc.(IRTC) of a Class Action Lawsuit and an Upcoming DeadlineMarch 14, 2024 | prnewswire.comIRTC Investors Have Opportunity to Lead iRhythm Technologies, Inc. Securities Fraud LawsuitMarch 13, 2024 | stockhouse.comIRTC SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit!March 12, 2024 | prnewswire.comInvestors who lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class Action - IRTCMarch 11, 2024 | markets.businessinsider.comKirby McInerney LLP Reminds Investors of Lead Plaintiff Deadline in iRhythm Technologies, Inc. (IRTC) Securities Class ActionMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTCMarch 11, 2024 | prnewswire.comIRTC Investors Have Opportunity to Lead iRhythm Technologies, Inc. Securities Fraud LawsuitMarch 11, 2024 | prnewswire.comThe Gross Law Firm Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTCMarch 11, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)March 9, 2024 | stockhouse.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythmMarch 9, 2024 | prnewswire.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTCMarch 8, 2024 | prnewswire.comIRHYTHM SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTCMarch 8, 2024 | finance.yahoo.comiRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional NotesMarch 8, 2024 | globenewswire.comiRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers' $86.25 Million Option to Purchase Additional NotesMarch 7, 2024 | prnewswire.comLost Money on iRhythm Technologies, Inc.(IRTC)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmMarch 6, 2024 | edition.cnn.comiRhythm Technologies, Inc.March 6, 2024 | finance.yahoo.comInsider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC)See More Headlines Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today3/18/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,000Year FoundedN/APrice Target and Rating Average Stock Price Target$135.11 High Stock Price Target$165.00 Low Stock Price Target$110.00 Potential Upside/Downside+28.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($4.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-123,410,000.00 Net Margins-25.05% Pretax Margin-24.90% Return on Equity-56.38% Return on Assets-28.63% Debt Debt-to-Equity Ratio0.17 Current Ratio2.15 Quick Ratio2.02 Sales & Book Value Annual Sales$492.68 million Price / Sales6.61 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book15.34Miscellaneous Outstanding Shares30,980,000Free Float30,846,000Market Cap$3.26 billion OptionableOptionable Beta1.30 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Quentin S. Blackford (Age 45)President, CEO & Director Comp: $2.15MMr. Brice Bobzien CPA (Age 45)Chief Financial Officer Comp: $685.12kDr. Minang P. Turakhia M.D. (Age 50)M.S., Chief Medical & Scientific Officer and Executive VP of Product Innovation Comp: $1MMr. Patrick Michael Murphy J.D. (Age 45)Chief Business & Legal Officer Comp: $1.28MMr. Douglas J. Devine (Age 54)Executive Advisor Comp: $800kMr. Chad M. Patterson (Age 42)Chief Commercial Officer Comp: $771.51kMr. Marc Rosenbaum (Age 52)Senior VP of Finance & Chief Accounting Officer Mr. Mark J. Day Ph.D. (Age 53)Chief Technology Officer Comp: $718.76kMr. Daniel G. Wilson (Age 41)Executive VP of Corporate Development & Investor Relations Comp: $670.09kMs. Sumi Shrishrimal (Age 45)Executive VP & Chief Risk Officer More ExecutivesKey CompetitorsAxonicsNASDAQ:AXNXIntegra LifeSciencesNASDAQ:IARTHaemoneticsNYSE:HAEPROCEPT BioRoboticsNASDAQ:PRCTICU MedicalNASDAQ:ICUIView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 35,694 shares on 3/11/2024Ownership: 9.663%Wellington Management Group LLPSold 1,196 shares on 3/5/2024Ownership: 0.704%Goldman Sachs Group Inc.Sold 122,635 shares on 3/1/2024Ownership: 0.519%Quentin S BlackfordSold 24,701 sharesTotal: $3.01 M ($121.96/share)Mark J DaySold 1,475 sharesTotal: $179,891.00 ($121.96/share)View All Insider TransactionsView All Institutional Transactions IRTC Stock Analysis - Frequently Asked Questions Should I buy or sell iRhythm Technologies stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks. What is iRhythm Technologies' stock price target for 2024? 8 Wall Street research analysts have issued 1-year price objectives for iRhythm Technologies' shares. Their IRTC share price targets range from $110.00 to $165.00. On average, they predict the company's stock price to reach $135.11 in the next twelve months. This suggests a possible upside of 32.1% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts. How have IRTC shares performed in 2024? iRhythm Technologies' stock was trading at $107.04 at the start of the year. Since then, IRTC stock has decreased by 4.4% and is now trading at $102.29. View the best growth stocks for 2024 here. Are investors shorting iRhythm Technologies? iRhythm Technologies saw a increase in short interest during the month of February. As of February 29th, there was short interest totaling 1,800,000 shares, an increase of 44.0% from the February 14th total of 1,250,000 shares. Based on an average trading volume of 407,100 shares, the short-interest ratio is currently 4.4 days. View iRhythm Technologies' Short Interest. When is iRhythm Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our IRTC earnings forecast. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its quarterly earnings data on Thursday, February, 22nd. The company reported ($1.26) EPS for the quarter, missing the consensus estimate of ($0.60) by $0.66. The business had revenue of $132.51 million for the quarter, compared to analysts' expectations of $131.14 million. iRhythm Technologies had a negative net margin of 25.05% and a negative trailing twelve-month return on equity of 56.38%. What ETFs hold iRhythm Technologies' stock? ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), BNY Mellon Innovators ETF (BKIV) and Fidelity Disruptive Medicine ETF (FMED). What guidance has iRhythm Technologies issued on next quarter's earnings? iRhythm Technologies updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $581.1 million. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA). When did iRhythm Technologies IPO? (IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.77%), Vanguard Group Inc. (9.66%), Capital Research Global Investors (8.14%), Sands Capital Management LLC (7.30%), Artisan Partners Limited Partnership (6.76%) and Mackenzie Financial Corp (4.13%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IRTC) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetryThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.